Download PDF
1 / Pages

Other users also viewed these articles

From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America. Federico Piñero; Ezequiel Mauro; Paola Casciato; Alejandro Forner;
Ann Hepatol. 2024;29:
Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC Federico Piñero; Margarita Anders; Carla Bermudez; Ezequiel Demirdjian; Adriana Varón; Ana Palazzo; Jorge Rodriguez; Oscar Beltrán; Leonardo Gomes da Fonseca; Ezequiel Ridruejo; Pablo Caballini; Norberto Tamagnone; Virginia Reggiardo; Hugo Cheinquer; Alexandre Araujo; Diego Arufe; Juan Ignacio Marín; Natalia Ratusnu; Estela Manero; Daniela Perez; Marina Villa; Federico Orozco; Dolores Murga; Sebastián Marciano; Fernando Bessone; Marcelo Silva; Manuel Mendizabal;
Ann Hepatol. 2023;28:
Usefulness of neutrophil-to-lymphocyte ratio (NLR) as a prognostic predictor after treatment of hepatocellular carcinoma. Review article Mohamad Mouchli; Shravani Reddy; Miranda Gerrard; Lisa Boardman; Marrieth Rubio;
10.1016/j.aohep.2020.08.067